Comparison of risk factors for candidemia versus bacteremia in hospitalized patients

被引:22
作者
Amrutkar, P. P.
Rege, M. D.
Chen, H.
LaRocco, M. T.
Gentry, L. O.
Garey, K. W.
机构
[1] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[2] St Lukes Episcopal Hosp, Houston, TX 77030 USA
关键词
D O I
10.1007/s15010-006-5677-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Classic risk factors for candidemia include use of total parenteral nutrition (TPN), hospital location, use of central venous catheter, and others. Unfortunately, most of these variables are now also risk factors for antibiotic-resistant bacteria. Thus, use of these risk factors to identify patients at high risk for candidemia is difficult. The purpose of this study was to compare these classic risk factors for candidemia in patients with bloodstream infections to determine the relative strength of these predictors in differentiating patients with candidemia and bacteremia. Methods: Clinical data were collected from the medical charts of patients who had been hospitalized between 2002 and 2004. Patients with their first episode of candidemia or bacteremia during their hospital stays were included. Risk factors were assessed using a multivariate logistic regression model and internally validated using a bootstrap analysis. A p-value < 0.05 was considered significant. Results: A total of 164 patients (82 with candidemia) were evaluated. According to the logistic analysis, patients who had stayed in the intensive care unit (ICU) (OR = 6.24; 95% CI: 2.58-15.09) or had been using TPN (OR = 4.69; 95% CI: 1.76-12.48) were more likely to have candidemia than bacteremia. While patients with pulmonary (OR = 0.15; 95% CI: 0.055-0.39) or cardiac disease (OR = 0.21; 95% CI: 0.086-0.51) had a greater chance to have bacteremia than candidemia (p < 0.01 for all variables). These results were further validated using bootstrap analysis. Conclusion: Among classic risk factors for candidemia, the ICU location at the time of culture and TPN use were most predictive of candidemia while certain medical disorders predicted patients at the highest risk for bacteremia. These results can be used to help identify patients most likely to benefit from empiric antifungal therapy.
引用
收藏
页码:322 / 327
页数:6
相关论文
共 30 条
[11]   Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals [J].
Macphail, GLP ;
Taylor, GD ;
Buchanan-Chell, M ;
Ross, C ;
Wilson, S ;
Kureishi, A .
MYCOSES, 2002, 45 (5-6) :141-145
[12]   Temporal assessment of Candida risk factors in the surgical intensive care unit [J].
McKinnon, PS ;
Goff, DA ;
Kern, JW ;
Devlin, JW ;
Barletta, JF ;
Sierawski, SJ ;
Mosenthal, AC ;
Gore, P ;
Ambegaonkar, AJ ;
Lubowski, TJ .
ARCHIVES OF SURGERY, 2001, 136 (12) :1401-1408
[13]   Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients [J].
Michalopoulos, AS ;
Geroulanos, S ;
Mentzelopoulos, SD .
CHEST, 2003, 124 (06) :2244-2255
[14]   Global trends in Candidemia: Review of reports from 1995-2005 [J].
Morgan J. .
Current Infectious Disease Reports, 2005, 7 (6) :429-439
[15]   Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality [J].
Morrell, M ;
Fraser, VJ ;
Kollef, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) :3640-3645
[16]   Risk factors for breakthrough candidemia [J].
Nucci, M ;
Colombo, AL .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (03) :209-211
[17]   New approaches to the risk of Candida in the intensive care unit [J].
Ostrosky-Zeichner, L .
CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (06) :533-537
[18]   Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species [J].
Peset, V ;
Tallón, P ;
Sola, C ;
Sánchez, E ;
Sarrión, A ;
Pérez-Bellés, C ;
Vindel, A ;
Cantón, E ;
Gobernado, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (10) :742-749
[19]   National surveillance of nosocomial blood stream infection due to Candida albicans:: Frequency of occurrence and antifungal susceptibility in the SCOPE Program [J].
Pfaller, MA ;
Jones, RN ;
Messer, SA ;
Edmond, MB ;
Wenzel, RP .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 31 (01) :327-332
[20]   CANDIDA COLONIZATION AND SUBSEQUENT INFECTIONS IN CRITICALLY ILL SURGICAL PATIENTS [J].
PITTET, D ;
MONOD, M ;
SUTER, PM ;
FRENK, E ;
AUCKENTHALER, R .
ANNALS OF SURGERY, 1994, 220 (06) :751-758